Zoic Capital

Zoic Capital targets early-stage companies in technology and life sciences. The firm typically invests at Seed and Series A stages, focusing on companies with defensible intellectual property in complex, often regulated markets. Its approach combines deep fundamental research with active partnership alongside founding teams.

Zoic Capital was established in 2015. Information about its founding partners and current investment team is not publicly available. The firm's filings indicate a traditional venture capital partnership structure.

Zoic Capital has not publicly disclosed its assets under management. Based on its early-stage focus and venture fund structure, the firm likely operates with a sub-$100 million fund size, consistent with emerging venture managers making Seed and Series A investments.

Zoic Capital primarily focuses on North American companies. The firm has indicated selective exposure to European early-stage opportunities, though the majority of its known activity centers on US-based technology and life sciences companies.

No. Zoic Capital is structured as a venture capital fund manager, not a family office. It operates through a series of Delaware limited liability companies and raises capital from external limited partners, consistent with a traditional venture capital firm model.